153 related articles for article (PubMed ID: 37726067)
41. Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.
Jiang Q; Tong HX; Hou YY; Zhang Y; Li JL; Zhou YH; Xu J; Wang JY; Lu WQ
Orphanet J Rare Dis; 2017 May; 12(1):97. PubMed ID: 28535796
[TBL] [Abstract][Full Text] [Related]
42. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract][Full Text] [Related]
43. Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib.
Mansfield AS; Murphy SJ; Harris FR; Robinson SI; Marks RS; Johnson SH; Smadbeck JB; Halling GC; Yi ES; Wigle D; Vasmatzis G; Jen J
Ann Oncol; 2016 Nov; 27(11):2111-2117. PubMed ID: 27742657
[TBL] [Abstract][Full Text] [Related]
44. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
Liu Q; Kan Y; Zhao Y; He H; Kong L
Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
[TBL] [Abstract][Full Text] [Related]
45. Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature.
Lasota J; Chłopek M; Wasąg B; Kowalik A; Christiansen J; Lamoureux J; Kuźniacka A; Felisiak-Gołąbek A; Liu Y; Reyes TAR; Saha R; Agaimy A; Behenska K; Biernat W; Cattaneo L; Centonze G; Daum O; Daumova M; Domagała P; Dziuba I; Geppert CE; Góźdź S; Nasierowska-Guttmejer A; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ryś J; Waloszczyk P; Wejman J; Miettinen M
Am J Surg Pathol; 2020 Sep; 44(9):1224-1234. PubMed ID: 32804454
[TBL] [Abstract][Full Text] [Related]
46. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
[TBL] [Abstract][Full Text] [Related]
47. Epithelioid sarcoma-like hemangioendothelioma.
Billings SD; Folpe AL; Weiss SW
Am J Surg Pathol; 2003 Jan; 27(1):48-57. PubMed ID: 12502927
[TBL] [Abstract][Full Text] [Related]
48. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
[TBL] [Abstract][Full Text] [Related]
49. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
50. Anaplastic Large-cell Lymphoma Involving Gastrointestinal Tract: A Clinicopathologic Study of 25 Cases of a Rare Tumor at a Rare Site.
Ud Din N; Rahim S; Ansar Z; Ahmed A; Ahmad Z
Int J Surg Pathol; 2023 Oct; 31(7):1195-1205. PubMed ID: 36514288
[No Abstract] [Full Text] [Related]
51. ALK-rearranged renal cell carcinoma: a multi-institutional study of nine cases with expanding the morphologic and molecular genetic spectrum.
Zhao M; Yin X; Yang X; Gan H; Chen N; Duan G; Bai Y; Teng X; Xu J; Fang R; Wang S; Zhong S; Wang X; Teng L
Mod Pathol; 2024 Jun; ():100536. PubMed ID: 38852815
[TBL] [Abstract][Full Text] [Related]
52. Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing.
Walther C; Hofvander J; Nilsson J; Magnusson L; Domanski HA; Gisselsson D; Tayebwa J; Doyle LA; Fletcher CD; Mertens F
Lab Invest; 2015 Sep; 95(9):1071-6. PubMed ID: 26121314
[TBL] [Abstract][Full Text] [Related]
53. Spitz nevus with EHBP1-ALK fusion and distinctive membranous localization of ALK.
Bahrani E; Kunder CA; Teng JM; Brown RA; Rieger KE; Novoa RA; Cloutier JM
J Cutan Pathol; 2022 Jun; 49(6):584-588. PubMed ID: 35113459
[TBL] [Abstract][Full Text] [Related]
54. Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation.
Georgantzoglou N; Green D; Winnick KN; Sumegi J; Charville GW; Bridge JA; Linos K
Genes Chromosomes Cancer; 2022 Aug; 61(8):471-480. PubMed ID: 35289445
[TBL] [Abstract][Full Text] [Related]
55. Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma.
Fadl A; Feldman AL
J Hematop; 2023 Jun; 16(2):125-126. PubMed ID: 37398940
[TBL] [Abstract][Full Text] [Related]
56. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
[TBL] [Abstract][Full Text] [Related]
57. TRAF7-mutated Fibromyxoid Spindle Cell Tumors Are Associated With an Aggressive Clinical Course and Harbor an Undifferentiated Sarcoma Methylation Signature: A Molecular and Clinicopathologic Study of 3 Cases.
Dermawan JK; Villafania L; Bale T; Singer S; D'Angelo SP; Tap WD; Antonescu CR
Am J Surg Pathol; 2023 Feb; 47(2):270-277. PubMed ID: 36395468
[TBL] [Abstract][Full Text] [Related]
58. A Novel CASC15-ALK and TFG-ROS1 Fusion Observed in Uterine Inflammatory Myofibroblastic Tumor.
Chang B; Wang Z; Ren M; Yao Q; Zhao L; Zhou X
Int J Gynecol Pathol; 2023 Sep; 42(5):451-459. PubMed ID: 36730016
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.
Li J; Yin WH; Takeuchi K; Guan H; Huang YH; Chan JK
Diagn Pathol; 2013 Sep; 8():147. PubMed ID: 24034896
[TBL] [Abstract][Full Text] [Related]
60. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]